EXECUTIVE LEADERSHIP

Bret Christensen is a seasoned leader recognized for his exceptional ability to launch innovative solutions, penetrate markets and effectively scale businesses. With over two decades of experience in the healthcare sector, a specialized focus on women’s health and a comprehensive understanding of the broader healthcare landscape, Bret has consistently proven his ability to elevate emerging solutions into market share leaders, solidifying his reputation as a catalyst for growth and success.

Over the course of his distinguished career, Bret has held strategic commercial and general management leadership roles at Hologic (NASDAQ: HOLX), Myriad Genetics (NASDAQ: MYGN) and Insulet (NASDAQ: PODD), where he played a central role in revolutionizing treatments in women’s health care, oncology and diabetes, respectively. His strategic leadership drove significant revenue growth, achieved product commercialization success and advanced groundbreaking therapies that have redefined standards of care.

Bret’s expertise spans diagnostics, therapeutics and medical devices, positioning him as the ideal leader to accelerate Biote to its next level of growth. With a rare blend of business acumen and deep industry insight, he is uniquely equipped to drive Biote’s continued success as a leading educator in hormone optimization and therapeutic wellness while expanding its market presence and reach.

Bret holds a Bachelor of Science from Utah Valley University, a Masters of Business Administration from the University of Utah, David Eccles School of Business and several executive certifications from the University of Chicago Booth School of Business.

Marc Beer brings more than 25 years of development and commercialization experience in biotechnology, pharmaceutical, device, and diagnostics and has served as CEO of Aegerion Pharmaceuticals, Inc. and ViaCell and as a member of the Erytech Pharma Board of Directors.

A member of the Miami University Business Advisory Council, Mark previously served as a member of the Notre Dame Research and Commercialization Advisory Committee and Notre Dame Graduate Studies Research and Advisory Council.

Marc has led several companies through significant capital raises and public offerings, including Renovia, LumeNXT Inc., Origami Surgical, Liftique, and Minerva Neurosciences Inc. His extensive experience as a Founder, CEO, and Chairman in numerous health-related companies makes him an ideal contributor to support Biote’s growth initiatives.

Bob Peterson brings to Biote 25 years of domestic and international finance, accounting, and operational experience across several industries – most notably Pharmaceuticals, Medical Device, and Financial Services. Bob has extensive experience in high growth businesses; as CFO, he has managed not only the traditional finance and accounting functions but also has been instrumental in leading commercial teams, data analytics, operational effectiveness programs, and supply chain activities.

Bob served as the Executive Vice President and Chief Financial Officer of Virbac Corporation, as subsidiary of Virbac S.A., a global Veterinary Pharmaceutical and Wellness company. Bob spent eight years at Alcon Labs/Novartis Eye Care, where he held roles of progressive responsibility including Global Head of Business Planning and Analysis as well as roles in Investor Relations.

Bob seeks to further Biote’s goals to become the leading provider of evidenced-based therapeutic wellness solutions by driving financial and operational excellence while providing strategic leadership and direction. His focus on financial planning and analysis, data analytics, and profitable growth will support Biote’s mission.

Bob holds a Bachelor of Business Administration in Finance and a Masters of Business Administration, both from Texas Christian University, Neeley School of Business.

James is the Chief People Officer for Biote. His 25+ years of leadership and human resources experience equips him to lead the development and execution of people and organization optimization strategies in pursuit of growth, operational excellence, and people & organizational development. In addition to the Biote Operating System, James leads all aspects of human resources, including talent management, employee engagement, development, HRIS, and total rewards. A strategic thinker with hands-on domestic and international experience, James has a track record of delivering business-centric HR support that modernizes and transforms the function to be an accelerator of business success.

James’ previous experiences span multiple industries, including manufacturing, logistics, consumer packaged goods, financial services, and healthcare. He has served in global leadership roles with companies such as McKesson, Frito-Lay, Dupont, GE, and Ford Motor Company and was a former Captain in the United States Marines Corps. Most recently he was the interim Chief People Officer for P3 Health Partners.

James has a JD from the Ohio State University Moritz College of Law and a BA in Political Science from Hampton University.

James lives in Dallas and has three grown children, sons Jordan and Zachary, and daughter Danielle. For fun, he competes in Tough Mudder sanctioned obstacle course races across the country.

Kevin Key is the Chief Digital Officer for Biote. With over 24 years of experience in the marketing and advertising industry, Kevin has a proven track record of leading and managing high-performing teams for world-class brands in various industries including automotive, CPG, financial services, travel, hospitality, retail, pharmaceutical, and telecommunications.

Prior to joining Biote, Kevin served as the Vice President of Digital Marketing for Mr. Cooper/Nationstar Mortgage, where he led digital marketing efforts for the 3rd largest home servicer in the country with $21B in loans originated. Before that, Kevin was the AVP Digital Marketing for General Motors, overseeing digital marketing for the financial division. Kevin also spent 18 years in leadership positions at marketing agencies, managing brands such as P&G, General Motors, Southwest Airlines, Dominos, Eli Lilly, and GlaxoSmithKline.

Kevin brings a wealth of experience and a passion for business strategy, insights, creative, data, analytics, and technology to lead Biote through its growth and digital transformation.

With over 35 years of experience in the healthcare marketing industry, Joel Pickering serves as the Chief Marketing Officer for Biote. Driven by his passion for health and wellness, Joel joined Biote to help lead and shape the future of the company’s marketing strategy.

Throughout his career, Joel has spearheaded award-winning global marketing initiatives for medical devices and biologic products. He has a proven track record of expanding market share and increasing visibility across diverse healthcare audiences. His leadership is marked by a forward-thinking vision and a relentless drive for innovation, always inspiring teams to achieve exceptional results.

Before joining Biote, Joel held senior roles including General Manager – USA for Systagenix Wound Management, Vice President of Marketing at PolyRemedy, Vizient, Inc., and Urgo Medical North America. He also served as President and Sales & Marketing Lead for TRX BioSurgery for six years, where he played a pivotal role in defining branding strategies, product development, and market expansion.

Joel earned a Bachelor of Science in Communications from The University of Texas at Austin.

As Biote’s General Counsel, Marybeth Conlon brings more than 17 years of professional law experience and expertise. Marybeth Conlon is founder of The Conlon Law Firm and began her legal career at Travis & Thompson, P.C. in Dallas where she was named partner at Travis, Calhoun & Conlon, P.C. She is a member of the Business Law, Construction Law, Labor and Employment Law, Litigation, and Real Estate, Probate, and Trust Law Sections of the Texas State Bar. Marybeth is also a member of the State Bar of Texas, Dallas Bar Association, Dallas Chapter of the Federal Bar Association, Texas Young Lawyers Association, and serves as a Fellow of the Dallas Bar Association Foundation.

In 2011, Marybeth was selected by the readers of Addison Magazine as one of twelve nominees for the magazine’s Top Female Executive award. Since 2012, she has been selected for inclusion in Thomson Reuters’ Texas Super Lawyers–Rising Stars Edition and in 2021, was selected for inclusion in Thomson Reuters’ Texas Super Lawyers.

Marybeth has served two terms as the President of the Circle of Friends Board for New Friends New Life, and is a member of the Dallas Museum of Art League, Stewpot Alliance, Equest Women’s Auxiliary, Genesis Alliance, Women’s Auxiliary to Children’s Medical Center, the Partnership / Community Partners of Dallas Women’s Auxiliary, Dallas Opera Women’s Board, and The Crystal Charity Ball and is an active member of the Owners Advisory Council.

A 25-year veteran of the IT industry, John has provided foundational technical and strategic leadership to high-growth, world-class companies. Prior to joining Biote, John served at CIO/CISO for Betacom, a leader in Private 5GaaS networks.  John also took on the role of COO for the Betacom 5GaaS business.

John Owned/Operated Integrity Home Therapy, a staffing company providing physical, occupational and speech therapists to the home care industry.  John led Goodman Networks Technology Strategy and Operations as CIO, John was also Co-Founder and President of LocoValue, Inc., a next generation iCommerce™ Company poised to change the online retail paradigm.

As Senior Vice President and CIO at MetroPCS, Inc., he pioneered a Cloud/SAAS/Managed Services strategy, creating the wireless industry’s most cost-effective and innovative IT organization. John also served as CIO and CTO at NEC Business Network Solutions and GTESS, respectively.

He chaired the CIO Forum for the Dallas Chamber of Commerce for 5 years and currently sits on boards at Southern Methodist University (SMU), University of Texas-Dallas (UTD), and Novus Academy. He holds an MA Degree from Webster University and BA Degree from Texas State University.

Terry Weber is a nationally recognized CEO and executive consultant who has transformed the business models of healthcare, retail, and automotive industry giants. Terry is known for being a disruptive leader, building extraordinary, high-performing, high-functioning teams and successfully navigating diverse industry sectors, seamlessly adapting them to the changing landscape of business and technological innovation.

Terry joined Biote to drive permanent industry innovation in the hormone optimization market, addressing the 200 million individuals in the U.S. who suffer from hormone imbalance.

Terry’s team-first focus has consistently resulted in growth, both in the financials of the $100 million to $2.5 billion companies she has led, and in the personal accomplishments of the individuals she has mentored. Her track record of accelerating growth includes Ford Motor Company, Advance Auto, British Petroleum, and Jiffy Lube, where Terry modernized and updated an industry once known for sleepy, regional stores into service-oriented and technology-driven retail chains. She has also worked with major consumer brands including Ann Taylor, Fredericks of Hollywood, Kroger, and Lowes Home Stores, helping them adapt and succeed in an increasingly competitive retail environment forever changed by e-commerce.

Terry was awarded the 50 Fastest-Growing Women-Owned/Led Companies of 2021 by the Women Presidents’ Organization (WPO) in collaboration with JP Morgan Chase Commercial Banking, and named one of PharmaVOICE’s 100 Most Inspiring People of 2021 in the life-sciences industry. Terry is a founding member of PreventiveMedicine.org and a board member of the International Women’s Foundation IWF.org.